Publisher's Synopsis
FDA user fees 2012: issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012.